Amy E. Bland

501 total citations
15 papers, 361 citations indexed

About

Amy E. Bland is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Amy E. Bland has authored 15 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Reproductive Medicine, 6 papers in Obstetrics and Gynecology and 3 papers in Surgery. Recurrent topics in Amy E. Bland's work include Endometrial and Cervical Cancer Treatments (6 papers), Uterine Myomas and Treatments (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Amy E. Bland is often cited by papers focused on Endometrial and Cervical Cancer Treatments (6 papers), Uterine Myomas and Treatments (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Amy E. Bland collaborates with scholars based in United States, Canada and Australia. Amy E. Bland's co-authors include Brian Calingaert, Angeles Alvarez Secord, Laura J. Havrilesky, Andrew Berchuck, Paula S. Lee, Fidel A. Valea, A. Alvarez-Secord, Teresa Rutledge, L. Havrilesky and Daniel L. Clarke‐Pearson and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, International Journal of Cancer and Obstetrics and Gynecology.

In The Last Decade

Amy E. Bland

14 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy E. Bland United States 10 229 185 66 57 43 15 361
Justine M. Briët Netherlands 7 349 1.5× 261 1.4× 51 0.8× 62 1.1× 46 1.1× 10 440
Maarit Vuento Finland 12 252 1.1× 244 1.3× 68 1.0× 67 1.2× 29 0.7× 25 451
Wagner José Gonçalves Brazil 9 179 0.8× 139 0.8× 46 0.7× 25 0.4× 51 1.2× 25 310
John McDonald United States 8 127 0.6× 227 1.2× 53 0.8× 88 1.5× 21 0.5× 9 303
Herbert Diebolder Germany 13 245 1.1× 293 1.6× 58 0.9× 122 2.1× 14 0.3× 23 417
Matteo Marchetti Italy 10 143 0.6× 145 0.8× 33 0.5× 70 1.2× 17 0.4× 43 282
Giulia Dondi Italy 11 221 1.0× 223 1.2× 46 0.7× 52 0.9× 25 0.6× 31 402
Konstantina Tatsi Greece 6 120 0.5× 169 0.9× 65 1.0× 87 1.5× 45 1.0× 6 329
Aeran Seol South Korea 9 149 0.7× 168 0.9× 70 1.1× 81 1.4× 51 1.2× 31 351
Hamdullah Sözen Türkiye 11 169 0.7× 158 0.9× 27 0.4× 45 0.8× 44 1.0× 44 297

Countries citing papers authored by Amy E. Bland

Since Specialization
Citations

This map shows the geographic impact of Amy E. Bland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy E. Bland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy E. Bland more than expected).

Fields of papers citing papers by Amy E. Bland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy E. Bland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy E. Bland. The network helps show where Amy E. Bland may publish in the future.

Co-authorship network of co-authors of Amy E. Bland

This figure shows the co-authorship network connecting the top 25 collaborators of Amy E. Bland. A scholar is included among the top collaborators of Amy E. Bland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy E. Bland. Amy E. Bland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bland, Amy E., et al.. (2024). Redefining feasibility in clinical trials: Collaborative approaches for improved site selection. Contemporary Clinical Trials Communications. 40. 101291–101291. 1 indexed citations
2.
Murila, Florence, et al.. (2011). Interpreting positive cultures of endotracheal aspirates: Factors associated with treatment decisions in ventilated neonates. Journal of Paediatrics and Child Health. 47(10). 728–733. 8 indexed citations
3.
Fleming, Nicole D., Laura J. Havrilesky, Fidel A. Valea, et al.. (2010). Analgesic and antiemetic needs following minimally invasive vs open staging for endometrial cancer. American Journal of Obstetrics and Gynecology. 204(1). 65.e1–65.e6. 17 indexed citations
4.
Lee, Paula S., Vanessa Teaberry, Amy E. Bland, et al.. (2009). Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer. International Journal of Cancer. 126(6). 1378–1389. 49 indexed citations
5.
Bernardini, Marcus Q., Taymaa May, Mahmoud A. Khalifa, et al.. (2009). Evaluation of Two Management Strategies for Preoperative Grade 1 Endometrial Cancer. Obstetrics and Gynecology. 114(1). 7–15. 15 indexed citations
6.
Neubauer, Nikki L., Laura J. Havrilesky, Brian Calingaert, et al.. (2009). The role of lymphadenectomy in the management of preoperative grade 1 endometrial carcinoma. Gynecologic Oncology. 112(3). 511–516. 46 indexed citations
7.
Bland, Amy E., Rebecca L. Stone, Cara Heuser, et al.. (2009). A Clinical and Biological Comparison Between Malignant Mixed Müllerian Tumors and Grade 3 Endometrioid Endometrial Carcinomas. International Journal of Gynecological Cancer. 19(2). 261–265. 22 indexed citations
8.
Lee, Paula S., Amy E. Bland, Fidel A. Valea, et al.. (2009). Robotic-Assisted Laparoscopic Gynecologic Procedures in a Fellowship Training Program. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 13(4). 467–472. 13 indexed citations
9.
Bland, Amy E., Brian Calingaert, Angeles Alvarez Secord, et al.. (2008). Relationship between tamoxifen use and high risk endometrial cancer histologic types. Gynecologic Oncology. 112(1). 150–154. 56 indexed citations
10.
Bland, Amy E., Elise Everett, Lisa M. Pastore, Willie A. Andersen, & Peyton T. Taylor. (2008). Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. International Journal of Gynecological Cancer. 18(4). 629–636. 3 indexed citations
11.
Bland, Amy E., et al.. (2008). Desmoplastic small round cell tumor masquerading as advanced ovarian cancer. International Journal of Gynecological Cancer. 18(4). 847–850. 4 indexed citations
12.
Bland, Amy E., et al.. (2008). Desmoplastic small round cell tumor masquerading as advanced ovarian cancer. International Journal of Gynecological Cancer. 18(4). 847–850.
13.
Schildkraut, Joellen M., Patricia G. Moorman, Amy E. Bland, et al.. (2008). Cyclin E Overexpression in Epithelial Ovarian Cancer Characterizes an Etiologic Subgroup. Cancer Epidemiology Biomarkers & Prevention. 17(3). 585–593. 12 indexed citations
14.
Alvarez-Secord, A., L. Havrilesky, Victoria Bae‐Jump, et al.. (2007). The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer. Gynecologic Oncology. 107(2). 285–291. 100 indexed citations
15.
Bland, Amy E., Elise Everett, Lisa M. Pastore, William Andersen, & Peyton T. Taylor. (2007). Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. International Journal of Gynecological Cancer. 18(4). 629–636. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026